Global BioPharmaceutical Tubing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global BioPharmaceutical Tubing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Biopharmaceutical tubing are specifically designed to meet critical needs of biopharmaceutical and medical industries. This tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps as well in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment. They confer exceptional thermal, mechanical, and chemical properties.

Market Overview:

The latest research study on the global BioPharmaceutical Tubing market finds that the global BioPharmaceutical Tubing market reached a value of USD 3225.73 million in 2022. It’s expected that the market will achieve USD 4775.43 million by 2028, exhibiting a CAGR of 6.76% during the forecast period.

Marketing channel sales will be affected differently

The COVID-19 Outbreak has led to a decline in offline passenger flow, and the advantages of e-commerce companies have become prominent. During the epidemic prevention and control period, some BioPharmaceutical Tubing enterprises did not carry out internet marketing and promotion for their business, so they encountered great resistance in undertaking business. For enterprises that fail to make good use of network promotion means, there is almost no market development during the epidemic period, and the original offline market development plan is disrupted, and the epidemic will face fierce market homogenization competition, which is expected to have a great impact on the company's business throughout the year.

Upstream and downstream interactions will lead to disruption of business

The epidemic will have a short-term impact on BioPharmaceutical Tubing industry, but it is relatively limited. Due to the impact of the epidemic, the production of raw materials and equipment procurement and transportation supply are difficult to be in place, and upstream enterprises affect the work schedule of downstream enterprises. Equipment manufacturing and product manufacturing enterprises in BioPharmaceutical Tubing industry are affected to different degrees, and the production and delivery work may be delayed to some extent. Meanwhile, if it fails to meet the customer's delivery time requirements according to the contract, it may lead to the customer looking for another enterprise and lose business.
Apart from this, the COVID-19 outbreak has resulted in the closing down of several manufacturing facilities across the globe. The pandemic caused huge revenue losses in end-use industry. The coronavirus lockdown put a brake on the production of several key raw materials in the global market, which, in turn, spiked the prices and lowered the demand for the product. The strict lockdown mandates imposed by governments have restricted cross-border trade between countries, another factor proving to be detrimental for the BioPharmaceutical Tubing market share. In addition, BioPharmaceutical Tubing manufacturers are drawing up plans for the international market as a new supply link in the global BioPharmaceutical Tubing industry, as companies look to re-engineer supply chains in the aftermath of COVID-19. Also, it is expected that the product demand in end-user sectors could pick up following the uplift of the lockdown in numerous countries.

Rising Demand for Minimally Invasive Procedures Contributes Significantly to Market Growth

A minimally invasive medical procedure is generally carried out by inserting a small device or an implant in body through an incision or anatomical opening. The popularity of these procedures has increased in the recent years due to the involvement of tiny incisions, faster recovery of patients, and less discomfort caused to the patients. Moreover, these procedures are also associated with benefits such as less trauma to muscles, nerves, tissues, and organs; less bleeding and scarring; and minimal injuries to tissues and less pain.
The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Furthermore, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing.

Stiff competition

The BioPharmaceutical Tubing market is competitive owing to a large number of manufacturers present globally. In order to sustain in the highly competitive market, major players are offering quality products at considerably lower cost. This could result into reduced profits, which is a factor restraining revenue growth of the target market. The presence of numerous players that offers BioPharmaceutical Tubing at lower prices to attract price-sensitive customers poses a significant threat to the market. Despite steady sales, the market for BioPharmaceutical Tubing has failed to achieve its full potential owing to competitive pricing strategies applied by regional players.
With major manufacturers and suppliers in the BioPharmaceutical Tubing industry competing at globally, the intensity of competition within the BioPharmaceutical Tubing industry has increased. The vendors adopt strategies like price premiums to stay competitive in the market. Meanwhile, the local vendors in developing nations are providing tough competition to the global players based on product pricing. The fierce competition is not conducive to the sustainable development of the industry. At the same time, small companies or small retailers enter the business consequently as venturing into a BioPharmaceutical Tubing business does not require immense capital or investment. However, this leads to the proliferation of sub-standard or duplicate products which then hampers the competitive scenario in the market as established BioPharmaceutical Tubing manufacturers are compelled to lower the price of their products, which ultimately impacts their profit margins and sales volumes. The fierce competition is not conducive to the sustainable development of the industry

Region Overview:

Geographically, North America held the largest market share – 39.24% in 2022.

Company Overview:

Saint-Gobain is one of the major players operating in the BioPharmaceutical Tubing market, holding a share of 8.26% in 2023.

Saint-Gobain

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in living places and daily life: in buildings, transportation, infrastructure and in so many industrial applications.

Corning

Corning is one of the world's leading innovators in materials science, with a 169-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramics science, and optical physics, along with its deep manufacturing and engineering capabilities, to develop category-defining products that transform industries and enhance people's lives.

Segmentation Overview:

Among different product types, Silicone segment is anticipated to contribute the largest market share in 2028.

Application Overview:

The market's largest segment by application is the segment Hospitals & Clinics, with a market share of 45.16% in 2022.

Key Companies in the global BioPharmaceutical Tubing market covered in Chapter 3:

Saint-Gobain
Nordson Corporation
NewAge Industries, Inc.
Corning
Optinova
Tekni-Plex
WL Gore & Associates
RAUMEDIC
DuPont
Lubrizol Corporation
Freudenberg Group
Teleflex
SCHOTT AG
Qure Medical
Putnam Plastics
Zeus Industrial Products

In Chapter 4 and Chapter 14.2, on the basis of types, the BioPharmaceutical Tubing market from 2018 to 2029 is primarily split into:

Plastics
Silicone
Glass
Metals

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the BioPharmaceutical Tubing market from 2018 to 2029 covers:

Hospitals & Clinics,
Ambulatory Surgical Centers
Medical Labs
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)